gene expression
FDA Deems Allarity Therapeutics' Kidney Cancer Drug, CDx Regulatory Applications Incomplete
The FDA's Refusal to File letter said that the data were not sufficient to show benefit, and Allarity anticipates it will have to conduct a prospective trial.
Biocartis, Ophiomics Partner to Commercialize Gene Expression Prognostic Test for Liver Cancer
The collaborators will focus on the commercialization of HepatoPredict, a prognostic gene expression test to identify patients for liver transplantation.
Multiple Myeloma Patient Similarity Network Reveals Prognostically Informative Subgroups
Researchers identified 12 multiple myeloma subgroups based on mutation, copy number, chromosomal rearrangement, and expression features in more than 650 tumors.
Early ESMO Data Show Interferon Signature's Ability to Guide Neoadjuvant Melanoma Immunotherapy
In the Phase I DOMINI trial, patients received combinations of BMS' Opdivo, Yervoy, and 4SC's domatinostat based on their tumors' interferon gamma gene expression.
Through its real-world evidence registry, the firm hopes to further validate its NSCLC recurrence risk test as a tool for guiding adjuvant treatment.